Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions)
Christoph Rageth(Hôpital Beau-Séjour), Zsuzsanna Varga(Zurich Heart House), Michael Knauer(Breast Center), Alexander Mundinger, R. Huch(Kantonsspital Baden), Elizabeth A. Morris(University of California Davis Medical Center), Thomas Decker, Caroline Malhaire(Université Paris Sciences et Lettres), Maria Pia Foschini(Ospedale Bellaria), Eva Maria Fallenberg(TUM Klinikum), Elizabeth O’Flynn(Institute of Cancer Research), Sophie Dellas(University of Basel), Martin Sonnenschein(Engeriedspital), Florian Dammann(University Hospital of Bern), Andreas Boos(University Hospital of Zurich), Pascal Baltzer(Medical University of Vienna), Christoph Tausch(Breast Center), Katja Pinker(Medical University of Vienna)
Cited by 251
Related Papers
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|The Lancet Oncology|2014|1.7k
The surgical destabilization of the medial meniscus (DMM) model of osteoarthritis in the 129/SvEv mouse
|Osteoarthritis and Cartilage|2007|1.5k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991